All Stories

  1. Role of C-Reactive Protein in Kidney Diseases
  2. Neural transcription factor Pou4f1 promotes renal fibrosis via macrophage–myofibroblast transition
  3. Bone marrow‐derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells
  4. LRNA9884, a Novel Smad3-Dependent Long Noncoding RNA, Promotes Diabetic Kidney Injury in db/db Mice via Enhancing MCP-1–Dependent Renal Inflammation
  5. Cardiomyocyte-specific loss of RMP causes myocardial dysfunction and heart failure
  6. Role of C-reactive protein in the pathogenesis of acute kidney injury
  7. Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs
  8. Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells
  9. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in db/db Mice by Targeting miR-29b
  10. C-reactive protein and ageing
  11. Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury
  12. Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment
  13. C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E
  14. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models
  15. miRNA-29b improves bone healing in mouse fracture model
  16. Validity of leptin receptor-deficiency (db/db) type 2 diabetes mellitus mice as a model of secondary osteoporosis
  17. C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway
  18. TGF-β: the master regulator of fibrosis
  19. The decreased expression of electron transfer flavoprotein β is associated with tubular cell apoptosis in diabetic nephropathy
  20. Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress
  21. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats
  22. Identification of Genes Associated with Smad3-dependent Renal Injury by RNA-seq-based Transcriptome Analysis
  23. Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes
  24. Renoprotective effect of berberine on type 2 diabetic nephropathy in rats
  25. Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation
  26. Expression of Human Tissue Factor Pathway Inhibitor on Vascular Smooth Muscle Cells Inhibits Secretion of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerosis in ApoE −/− Mice
  27. TGF-β/Smad signaling in renal fibrosis
  28. MicroRNAs in renal fibrosis
  29. N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice
  30. Latent Transforming Growth Factor-β1 Protects against Bleomycin-Induced Lung Injury in Mice
  31. Transforming growth factor‐β1 mediates psoriasis‐like lesions via a Smad3‐dependent mechanism in mice
  32. Macrophages promote renal fibrosis through direct and indirect mechanisms
  33. Partial loss of Smad7 function impairs bone remodeling, osteogenesis and enhances osteoclastogenesis in mice
  34. MicroRNAs in TGF-β/Smad-mediated Tissue Fibrosis
  35. MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis
  36. Opposing Roles for Smad2 and Smad3 in Peritoneal Fibrosis in Vivo and in Vitro
  37. Inflammatory processes in renal fibrosis
  38. miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling
  39. C-reactive protein promotes acute kidney injury by impairing G 1 /S-dependent tubular epithelium cell regeneration
  40. Application of microRNAs in diabetes mellitus
  41. Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension
  42. MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
  43. Chaihuang-Yishen Granule Inhibits Diabetic Kidney Disease in Rats through Blocking TGF-β/Smad3 Signaling
  44. Tissue Kallikrein Mediates Pro-Inflammatory Pathways and Activation of Protease-Activated Receptor-4 in Proximal Tubular Epithelial Cells
  45. Identification of Novel Long Noncoding RNAs Associated with TGF-β/Smad3-Mediated Renal Inflammation and Fibrosis by RNA Sequencing
  46. MicroRNAs in Diabetic Kidney Disease
  47. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway
  48. Dragon (Repulsive Guidance Molecule RGMb) Inhibits E-cadherin Expression and Induces Apoptosis in Renal Tubular Epithelial Cells
  49. MicroRNA and nephropathy: emerging concepts
  50. miR-30a Negatively Regulates TGF-β1–Induced Epithelial-Mesenchymal Transition and Peritoneal Fibrosis by Targeting Snai1
  51. Deficiency of Smad7 Enhances Cardiac Remodeling Induced by Angiotensin II Infusion in a Mouse Model of Hypertension
  52. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro
  53. Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma
  54. Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling
  55. Ribosomal protein S19 is a novel therapeutic agent in inflammatory kidney disease
  56. Distinct roles of Smads and microRNAs in TGF-β signaling during kidney diseases
  57. Role of the TGF-β/BMP-7/Smad pathways in renal diseases
  58. Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs
  59. Smad7 gene transfer attenuates angiogenesis in peritoneal dialysis rats
  60. Expression profile of macrophage migration‐inhibitory factor in human gingiva and reconstituted human gingival epithelia stimulated by Porphyromonas gingivalis lipopolysaccharide
  61. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
  62. Disruption of Smad7 Promotes ANG II-Mediated Renal Inflammation and Fibrosis via Sp1-TGF-β/Smad3-NF.κB-Dependent Mechanisms in Mice
  63. Transforming growth factor‐β/Smad signalling in diabetic nephropathy
  64. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer
  65. miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
  66. Loss of miR-29 in Myoblasts Contributes to Dystrophic Muscle Pathogenesis
  67. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy
  68. TGF-β/Smad Signaling in Kidney Disease
  69. Smads as therapeutic targets for chronic kidney disease
  70. Diverse roles of TGF‐β receptor II in renal fibrosis and inflammation in vivo and in vitro
  71. Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In Vitro
  72. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro
  73. Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease
  74. Smad3 mediates ANG II-induced hypertensive kidney disease in mice
  75. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice
  76. Additive renoprotective effects of B2-kinin receptor blocker and PPAR-γ agonist in uninephrectomized db/db mice
  77. Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
  78. TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
  79. C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes
  80. Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression
  81. Diabetes Complications: The MicroRNA Perspective
  82. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification
  83. C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice
  84. Differential effects of advanced glycation end-products on renal tubular cell inflammation
  85. Chemokines in Renal Injury
  86. Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
  87. Transforming Growth Factor-β and Smads
  88. Amelioration of Albuminuria in ROCK1 Knockout Mice with Streptozotocin-Induced Diabetic Kidney Disease
  89. A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr Mice
  90. The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
  91. Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer
  92. Essential role for Smad3 in angiotensin II‐induced tubular epithelial–mesenchymal transition
  93. Early Differential Expression of Oncostatin M in Obstructive Nephropathy
  94. Smad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
  95. A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
  96. miR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
  97. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer
  98. Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling
  99. C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II–Induced Hypertensive Cardiac Disease
  100. Mechanism of chronic aristolochic acid nephropathy: role of Smad3
  101. Lefty antagonises TGF-β1 induced epithelial–mesenchymal transition in tubular epithelial cells
  102. Renoprotection by Rosiglitazone in Accelerated Type 2 Diabetic Nephropathy: Role of STAT1 Inhibition and Nephrin Restoration
  103. Advanced Glycation End-Products Induce Tubular CTGF via TGF-β–Independent Smad3 Signaling
  104. Bradykinin and high glucose promote renal tubular inflammation
  105. Activation of p53 Promotes Renal Injury in Acute Aristolochic Acid Nephropathy
  106. Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–β–Dependent and –Independent Smad Pathways
  107. Impaired TGF-  signalling enhances peritoneal inflammation induced by E. Coli in rats
  108. Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer
  109. Identification of XAF1 as a novel cell cycle regulator through modulating G2/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer
  110. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver
  111. Peroxisome Proliferator-Activated Receptor-  Contributes to the Inhibitory Effects of Embelin on Colon Carcinogenesis
  112. Essential Role for Macrophage Migration Inhibitory Factor in Gastritis Induced by Helicobacter pylori
  113. Anti-Inflammatory and Renal Protective Actions of Stanniocalcin-1 in a Model of Anti-Glomerular Basement Membrane Glomerulonephritis
  114. Role of NAD(P)H oxidase in transforming growth factor-β1-induced monocyte chemoattractant protein-1 and interleukin-6 expression in rat renal tubular epithelial cells
  115. Treatment of Established Peritoneal Fibrosis by Gene Transfer of Smad7 in a Rat Model of Peritoneal Dialysis
  116. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice
  117. c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer
  118. Loss of XIAP sensitizes colon cancer cells to PPARγ independent antitumor effects of troglitazone and 15-PGJ2
  119. Transforming Growth Factor  1 Promotes Chromosomal Instability in Human Papillomavirus 16 E6E7-Infected Cervical Epithelial Cells
  120. Oncogene Functions of FHL2 Are Independent from NF-κBIα in Gastrointestinal Cancer
  121. Gene expression profile in colon cancer cells with respect to XIAP expression status
  122. Pentoxifylline Inhibits Transforming Growth Factor-Beta Signaling and Renal Fibrosis in Experimental Crescentic Glomerulonephritis in Rats
  123. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor   ligand-induced growth inhibition in colon cancer
  124. Mice overexpressing latent TGF-β1 are protected against renal fibrosis in obstructive kidney disease
  125. Suppression of pulmonary injury in experimental ‘Goodpasture's syndrome’ by deoxyspergualin (DSP)
  126. Trafficking of inflammatory macrophages from the kidney to draining lymph nodes during experimental glomerulonephritis
  127. Pancreatic duodenal homeobox-1 (PDX1) functions as a tumor suppressor in gastric cancer
  128. Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase Pathway
  129. CXCL9, but not CXCL10, Promotes CXCR3-Dependent Immune-Mediated Kidney Disease
  130. Latent TGF- 1 Protects Against Crescentic Glomerulonephritis
  131. Smad7 as a therapeutic agent for chronic kidney diseases
  132. Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancerin vivo
  133. Role of Macrophage Migration Inhibition Factor in Kidney Disease
  134. XIAP-Associated Factor 1 (XAF1) Suppresses Angiogenesis in Mouse Endothelial Cells
  135. Smad7 gene transfer inhibits peritoneal fibrosis
  136. Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat
  137. Smad7 Transgene Attenuates Peritoneal Fibrosis in Uremic Rats Treated with Peritoneal Dialysis
  138. Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7
  139. Immunopathologic Mechanisms Relevant to Diseases
  140. Smad7 Gene Therapy Ameliorates an Autoimmune Crescentic Glomerulonephritis in Mice
  141. Macrophage Migration Inhibitory Factor Induces MMP-9 Expression in Macrophages via The MEK-ERK MAP Kinase Pathway
  142. Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes
  143. Signaling Mechanism of Renal Fibrosis in Unilateral Ureteral Obstructive Kidney Disease in ROCK1 Knockout Mice
  144. Essential Role of Smad3 in Angiotensin II–Induced Vascular Fibrosis
  145. Advanced Glycation End Products Activate a Chymase-Dependent Angiotensin II–Generating Pathway in Diabetic Complications
  146. C5a Receptor Deficiency Attenuates T Cell Function and Renal Disease in MRLlpr Mice
  147. Critical Role of Macrophage Migration Inhibitory Factor Activity in Experimental Autoimmune Diabetes
  148. Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection
  149. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis
  150. Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney
  151. Signaling Mechanism of TGF-β1 in Prevention of Renal Inflammation: Role of Smad7
  152. Ultrasound-Microbubble-Mediated Gene Transfer of Inducible Smad7 Blocks Transforming Growth Factor-β Signaling and Fibrosis in Rat Remnant Kidney
  153. Role of ERK1/2 and p38 Mitogen-Activated Protein Kinases in the Regulation of Thrombospondin-1 by TGF-β1 in Rat Proximal Tubular Cells and Mouse Fibroblasts
  154. Transforming growth factor-beta and Smad signalling in kidney diseases. Review Article
  155. Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques
  156. Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques
  157. Differential regulation of VEGF by TGF-β and hypoxia in rat proximal tubular cells
  158. TGF-β induces proangiogenic and antiangiogenic factorsvia parallel but distinct Smad pathways
  159. Helicobacter pylori Infection Is Associated with Increased Expression of Macrophage Migratory Inhibitory Factor—by Epithelial Cells, T Cells, and Macrophages—in Gastric Mucosa
  160. Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase Signaling Pathway
  161. Pentoxifylline suppresses renal tumour necrosis factor-  and ameliorates experimental crescentic glomerulonephritis in rats
  162. Role of JAK/STAT Pathway in IL-6-Induced Activation of Vascular Smooth Muscle Cells
  163. Advanced glycation end products activate Smad signaling via TGF- -dependent and -independent mechanisms: implications for diabetic renal and vascular disease
  164. Chymase Is Upregulated in Diabetic Nephropathy: Implications for an Alternative Pathway of Angiotensin II-Mediated Diabetic Renal and Vascular Disease
  165. Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2
  166. Role of TGF-β signaling in extracellular matrix production under high glucose conditions
  167. Inhibition of Renal Fibrosis by Gene Transfer of Inducible Smad7 Using Ultrasound-Microbubble System in Rat UUO Model
  168. Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma
  169. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome
  170. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells
  171. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy
  172. Uric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity
  173. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients
  174. Effects of cyclosporine in osteopontin null mice
  175. Interleukin 1 induces renal CD44 expression in vivo and in vitro: role of the transcription factor Egr‐1
  176. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism
  177. Smad7 Inhibits Fibrotic Effect of TGF-  on Renal Tubular Epithelial Cells by Blocking Smad2 Activation
  178. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: Implication on mechanism of tubuloglomerular communication in glomerulopathic proteinura
  179. ROLE OF SMAD SIGNALING IN REGULATION OF RENAL OSTEOPONTIN EXPRESSION IN VITRO AND IN VIVO
  180. Reducing uric acid as a means to prevent cardiovascular and renal disease
  181. Macrophage Migration Inhibitory Factor Expression in Male and Female Ethanol-Fed Rats
  182. Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
  183. Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction
  184. Combined interleukin 1 and tumour necrosis factor α blockade in rat crescentic anti‐glomerular basement membrane glomerulonephritis
  185. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis
  186. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats
  187. Tubules are the major site of M-CSF production in experimental kidney disease: Correlation with local macrophage proliferation11See Editorial by Rovin, p. 797
  188. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-β1-dependent mechanism in vitro
  189. HYPERURICEMIA EXACERBATES CHRONIC CYCLOSPORINE NEPHROPATHY1
  190. Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells
  191. CD44-mediated neutrophil apoptosis in the rat
  192. Induction of neutrophil apoptosis through cross‐linking of the adhesion molecule CD44
  193. Osteopontin Expression in Progressive Renal Injury in Remnant Kidney: Role of Angiotensin II
  194. The role of platelet‐derived growth factor in a murine model of crescentic nephritis
  195. IL‐1‐induced, TGF‐β dependent tubular Epithelial‐Myofibroblast Transdifferentiation (TEMT) in renal fibrosis
  196. Expression of macrophage migration inhibitory factor in human glomerulonephritis
  197. Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II
  198. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease
  199. Expression of E-cadherin-catenin complex in the precancerous lesions in gastric cancer
  200. Characteristics of albumin processing during renal passage in Anti-Thy1 and anti–glomerular basement membrane glomerulonephritis
  201. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation
  202. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat
  203. Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro
  204. Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury
  205. IL-1 Up-Regulates Osteopontin Expression in Experimental Crescentic Glomerulonephritis in the Rat
  206. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis
  207. Cell-mediated tubulointerstitial nephritis
  208. MACROPHAGE MIGRATION INHIBITORY FACTOR EXPRESSION IN HUMAN RENAL ALLOGRAFT REJECTION1,2
  209. Macrophage migration inhibitory factor (MIF) - potential perspectives for immune-intervention in renal disease
  210. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats
  211. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney
  212. Local Regulation of Macrophage Subsets in the Adult Rat Testis: Examination of the Roles of the Seminiferous Tubules, Testosterone, and Macrophage-Migration Inhibitory Factor1
  213. Local macrophage proliferation in human glomerulonephritis
  214. Interleukin‐10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo
  215. Immunoregulatory Activity in Adult Rat Testicular Interstitial Fluid: Relationship with Intratesticular CD8+ Lymphocytes following Treatment with Ethane Dimethane Sulfonate and Testosterone Implants1
  216. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis
  217. Therapeutic effects of cytokine blockade in glomerulonephritis
  218. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis
  219. Molecular analysis of human glomerulonephritis
  220. Do macrophages participate in mesangial cell proliferation?
  221. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats
  222. Intrinsic renal cells are the major source of interleukin-1  synthesis in normal and diseased rat kidney
  223. Up-regulation of macrophage colony-stimulating factor (M-CSF) and migration inhibitory factor (MIF) expression and monocyte recruitment during lipid-induced glomerular injury in the exogenous hypercholesterolaemic (ExHC) rat
  224. The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat
  225. CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis
  226. Ultrastructural localisation of CD44 in the rat lung in experimental Goodpasture’s syndrome
  227. Delayed‐type hypersensitivity mediates Bowman's capsule rupture in Tamm—Horsfall protein‐induced tubulointerstitial nephritis in the rat
  228. Tubulointerstitial injury in glomerulonephritis
  229. The application of microwave techniques in multiple immunostaining and in situ hybridization
  230. A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology.
  231. A novel method of microwave treatment for detection of cytoplasmic and nuclear antigens by flow cytometry
  232. Dialyzer Reuse: Interaction Between Dialyzer Membrane, Disinfectant (Formalin), and Blood During Dialyzer Reprocessing
  233. Expression of basic fibroblast growth factor and its receptor in the progression of rat crescentic glomerulonephritis
  234. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis
  235. Up‐regulation of ICAM‐1 and VCAM‐1 expression during macrophage recruitment in lipid induced glomerular injury in ExHC rats
  236. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat
  237. Local macrophage proliferation in experimental Goodpasture's syndrome
  238. EGF and EGF‐receptor expression in rat anti‐Thy‐1 mesangial proliferative nephritis
  239. Deoxyspergualin: A New Immunosuppressive Drug for the Treatment of Auto-Immune Disease
  240. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens.
  241. DEOXYSPERGUALIN SUPPRESSES LOCAL MACROPHAGE PROLIFERATION IN RAT RENAL ALLOGRAFT REJECTION
  242. Leukocyte Populations of the Adult Rat Testis Following Removal of the Leydig Cells by Treatment With Ethane Dimethane Sulfonate and Subcutaneous Testosterone Implants1
  243. Adhesion molecules in glomerulonephritis
  244. The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis
  245. ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis
  246. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist
  247. Immune events in lymphoid tissues during experimental glomerulonephritis
  248. Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis
  249. Glomerulonephritis and Smad Signaling